- Home
- COLL vs PDM Comparison
COLL vs PDM Comparison
Compare COLL & PDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COLL | PDM |
|---|---|---|
| Founded | 2002 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building operators |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 2015 | 1997 |
Fundamental Metrics
Financial Performance| Metric | COLL | PDM |
|---|---|---|
| Price | $33.19 | $8.88 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $51.40 | $9.00 |
| AVG Volume (30 Days) | 384.8K | ★ 901.0K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.40 | N/A |
| Revenue | ★ $780,567,000.00 | $564,994,000.00 |
| Revenue This Year | $8.01 | $4.21 |
| Revenue Next Year | N/A | $1.29 |
| P/E Ratio | $81.73 | ★ N/A |
| Revenue Growth | ★ 23.62 | N/A |
| 52 Week Low | $29.08 | $6.32 |
| 52 Week High | $50.79 | $9.19 |
Technical Indicators
Market Signals| Indicator | COLL | PDM |
|---|---|---|
| Relative Strength Index (RSI) | 47.84 | 68.32 |
| Support Level | $31.56 | $7.92 |
| Resistance Level | $35.95 | $8.91 |
| Average True Range (ATR) | 1.20 | 0.19 |
| MACD | -0.15 | 0.05 |
| Stochastic Oscillator | 62.20 | 91.95 |
Price Performance
Historical ComparisonAbout COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.
About PDM Piedmont Office Realty Trust Inc.
Piedmont Realty Trust Inc is a fully integrated, self-managed real estate investment company focused on delivering an exceptional office environment. As an owner, manager, developer and operator of 16 MM SF of Class A properties across U.S. Sunbelt markets, Piedmont Realty Trust is known for its hospitality-driven approach and commitment to transforming buildings into Piedmont PLACEs that enhance each client's workplace experience.